Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2014-09-28 Regulatory Filings
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Immediate Report
Regulatory Filings
2014-09-28 Hebrew (modern)
Immediate Report
Capital/Financing Update Classification · 98% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. The key content states: 'Attached hereto is a report on *PRELIMINARY PROSPECTUS SUPPLEMENT*'. A Preliminary Prospectus Supplement relates to the offering of securities, which falls under financing activities or capital structure changes. Given the short length (1640 chars) and the explicit mention that a document (*PRELIMINARY PROSPECTUS SUPPLEMENT*) is attached, this filing is an announcement about a capital/financing event rather than the full prospectus itself. This aligns best with the 'Capital/Financing Update' category (CAP).
2014-09-28 English
Immediate Report
Regulatory Filings
2014-09-28 Hebrew (modern)
Immediate Report
Report Publication Announcement Classification · 98% confidence The document is very short (1619 characters) and explicitly states, "Attached hereto is a report on *XTL_FWP_SEP_2014_isa.pdf*". This structure—a brief announcement stating that a report is attached or published, rather than containing the full report content—fits the definition of a Report Publication Announcement (RPA). It is not a full financial report (like 10-K or IR) or a transcript (CT). The reference to the Israel Securities Authority and the format suggests a regulatory filing context, but the specific action described is the publication announcement.
2014-09-28 English
ISSUER FREE WRITING PROSPECTUS
Investor Presentation Classification · 95% confidence The document is titled 'Issuer Free Writing Prospectus' and references Rule 433, which is related to SEC filings for prospectuses used in securities offerings. It contains detailed information about the company, its management, clinical trials, market overview, and the use of proceeds from an offering. The document is a presentation-type summary aimed at investors regarding a securities offering, including forward-looking statements and risk factors. It is not a full financial report, earnings release, or regulatory certification. The content aligns with an investor presentation or offering document rather than an annual report or audit report. Given the nature of the document as a detailed presentation for investors focusing on financials, strategy, and market position related to a securities offering, the most appropriate classification is Investor Presentation (IP).
2014-09-26 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement and accompanying prospectus related to an offering of American Depositary Shares (ADSs) by XTL Biopharmaceuticals Ltd. It includes detailed information about the offering terms, risk factors, use of proceeds, underwriting, and company business overview. The document is a registration and offering prospectus filed pursuant to SEC rules, specifically Rule 424(b)(5), which relates to prospectus supplements for securities offerings. This type of document is neither a financial report, earnings release, nor a management discussion, but rather a capital raising disclosure document. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2014-09-26 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.